Literature DB >> 15505018

Use of aspirin to reduce risks of cardiovascular disease in patients with diabetes: clinical and research challenges.

Charles H Hennekens1, Genell L Knatterud, Marc A Pfeffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15505018     DOI： 10.2337/diacare.27.11.2752

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  An appraisal of aspirin therapy in diabetes.

Authors:  John A Colwell
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

2.  Telemedicine cardiovascular risk reduction in veterans.

Authors:  S Dee Melnyk; Leah L Zullig; Felicia McCant; Susanne Danus; Eugene Oddone; Lori Bastian; Maren Olsen; Karen M Stechuchak; David Edelman; Susan Rakley; Miriam Morey; Hayden B Bosworth
Journal:  Am Heart J       Date:  2013-02-28       Impact factor: 4.749

Review 3.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

4.  Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain.

Authors:  Antoni Sicras-Mainar; Ruth Navarro-Artieda; Javier Rejas-Gutiérrez; Jaime Fernández-de-Bobadilla; Xavier Frías-Garrido; Rafael Ruiz-Riera
Journal:  BMC Fam Pract       Date:  2007-10-17       Impact factor: 2.497
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.